Tag Archives: biotechnology

BIO’s take on the CBD Nagoya Protocol

After several years of negotiations, the 10th Conference of the Parties of the Convention on Biological Diversity (CBD) successfully adopted the Nagoya Protocol.  The Protocol provides benefits to the biotechnology industry by creating a legal framework to regulate access to genetic resources and provide fair and equitable sharing of benefits.  In addition, the Protocol does not apply retroactively or hinder regulation or a country’s intellectual property systems.  Assuming nations implement the Protocol appropriately, we can Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , , ,

BIO Press Release: BIO and AUTM file Amicus Brief in Myriad Case

The Biotechnology Industry Organization (BIO) filed an amicus brief in the U.S. Court of Appeals for the Federal Circuit on Friday, October 29th, in an appeal of a lawsuit brought by the American Civil Liberties Union on behalf of a number of plaintiffs against Myriad Genetics, the U.S. Patent and Trademark Office, and others. The brief, filed jointly with the Association of University Technology Managers (AUTM), supports the patentability of isolated DNA molecules, noting that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , ,

Secretary Sebelius speaks at biotech meeting

Secretary Sebelius delivered a speech in California yesterday which recognized the potential of biotechnology to address unmet needs in human health, agriculture and industrial and environmental applications.  In her remarks, Secretary Sebelius stated: “[I]nvesting in each step of the process that starts with basic scientific discovery and ends with the development and provision of better diagnostics, treatments, and preventive strategies to significantly improve health care.  I know I don’t have to tell you that because Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Getting to Market: The Challenges of Technology Transfer

An article about BIO’s recent Technology Transfer Symposium. Getting to Market: The Challenges of Technology Transfer Attendees at special symposium focus on issues of commercializing and licensing biotech discoveries Read the post on BIOtech NOW

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

New Blogger

Patently Biotech has a new writer.  My name is Roy Zwahlen and I am the new Intellectual Property manager at BIO.  I am an attorney and political science undergraduate and fascinated with intellectual property policy.  I am excited about this opportunity to enter the IP blogosphere. My hope is to provide information about BIO’s IP activities including conferences and amicus briefs.  I also hope to reintroduce our IP staff and spotlight our BIO company members.  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,